Cancer clinical trials in the region Pays de la Loire

240 currently recruiting clinical trials
Region Pays de la Loire

Phase 2 Lymphoma #NCT05463263
B cell lymphoma T cell lymphoma None 2 3 or more
Systemic Treatment-Naive
Centre Hospitalier Universitaire - Site Hôtel Dieu (Nantes)
Step Pharma, SAS
Phase 2 Liver and bile duct cancer #NCT03727633
Hepatocellular carcinoma Localized Unhealthy A B A B C None Systemic Treatment-Naive
Centre Hospitalier Universitaire Angers (Angers )
CHU de Montpellier
Phase 2 Lung cancer #NCT05742607
NSCLC (Non-Small Cell Lung Cancer) Localized None Systemic Treatment-Naive
ALK EGFR Immunotherapy Targeted therapy
Centre Hospitalier Universitaire Angers (Angers )
Innate Pharma
Phase 1 / Phase 2 #NCT05118789
Locally Advanced Metastatic ROS-1 1
Systemic Treatment-Naive
Centre Hospitalier Universitaire - Site Hôtel Dieu (Nantes)
Nuvalent Inc.
Phase 1 / Phase 2 Endometrial cancer #NCT04585750 #2023-504251-27-00
Locally Advanced Metastatic TP53 1 2 3 or more
KRAS G12C KRAS non G12C Systemic Treatment-Naive
Institut de Cancérologie de l'Ouest - Site de Saint-Herblain (Saint-Herblain)
PMV Pharmaceuticals, Inc
Phase 1 / Phase 2 Bladder / Urinary Tract / Urethral cancer #NCT04585750 #2023-504251-27-00
Locally Advanced Metastatic TP53 1 2 3 or more
KRAS G12C KRAS non G12C Systemic Treatment-Naive
Institut de Cancérologie de l'Ouest - Site de Saint-Herblain (Saint-Herblain)
PMV Pharmaceuticals, Inc
Phase 1 / Phase 2 Lung cancer #NCT04585750 #2023-504251-27-00
Locally Advanced Metastatic TP53 1 2 3 or more
KRAS G12C KRAS non G12C Systemic Treatment-Naive
Institut de Cancérologie de l'Ouest - Site de Saint-Herblain (Saint-Herblain)
PMV Pharmaceuticals, Inc
Phase 1 / Phase 2 Colon cancer Rectal cancer Anal cancer Kidney cancer Pancreas cancer Liver and bile duct cancer Stomach and esophageal cancer #NCT04585750 #2023-504251-27-00
Locally Advanced Metastatic TP53 1 2 3 or more
KRAS G12C KRAS non G12C Systemic Treatment-Naive
Institut de Cancérologie de l'Ouest - Site de Saint-Herblain (Saint-Herblain)
PMV Pharmaceuticals, Inc
Phase 1 / Phase 2 Prostate cancer #NCT04585750 #2023-504251-27-00
Metastatic Castration-resistant TP53 1 2 3 or more
KRAS G12C KRAS non G12C Systemic Treatment-Naive
Institut de Cancérologie de l'Ouest - Site de Saint-Herblain (Saint-Herblain)
PMV Pharmaceuticals, Inc
Phase 1 / Phase 2 Breast cancer #NCT04585750 #2023-504251-27-00
Locally Advanced Metastatic TP53 1 2 3 or more
KRAS G12C KRAS non G12C Systemic Treatment-Naive
Institut de Cancérologie de l'Ouest - Site de Saint-Herblain (Saint-Herblain)
PMV Pharmaceuticals, Inc